Cargando…
Discovery and development of novel DNA-PK inhibitors by targeting the unique Ku–DNA interaction
DNA-dependent protein kinase (DNA-PK) plays a critical role in the non-homologous end joining (NHEJ) repair pathway and the DNA damage response (DDR). DNA-PK has therefore been pursued for the development of anti-cancer therapeutics in combination with ionizing radiation (IR). We report the discover...
Autores principales: | Gavande, Navnath S, VanderVere-Carozza, Pamela S, Pawelczak, Katherine S, Mendoza-Munoz, Pamela, Vernon, Tyler L, Hanakahi, Leslyn A, Summerlin, Matthew, Dynlacht, Joseph R, Farmer, Annabelle H, Sears, Catherine R, Nasrallah, Nawar Al, Garrett, Joy, Turchi, John J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7672428/ https://www.ncbi.nlm.nih.gov/pubmed/33119767 http://dx.doi.org/10.1093/nar/gkaa934 |
Ejemplares similares
-
Ku–DNA binding inhibitors modulate the DNA damage response in response to DNA double-strand breaks
por: Mendoza-Munoz, Pamela L, et al.
Publicado: (2023) -
Recent Advances in the Development of Non-PIKKs Targeting Small Molecule Inhibitors of DNA Double-Strand Break Repair
por: Kelm, Jeremy M., et al.
Publicado: (2022) -
OB-Folds and Genome Maintenance: Targeting Protein–DNA Interactions for Cancer Therapy
por: Par, Sui, et al.
Publicado: (2021) -
In Vivo Targeting Replication Protein A for Cancer Therapy
por: VanderVere-Carozza, Pamela S., et al.
Publicado: (2022) -
Differential activation of DNA-PK based on DNA strand orientation and sequence bias
por: Pawelczak, Katherine S., et al.
Publicado: (2005)